Method for stimulating retinal response using photoactive devices
View Patent ↗An improved method for stimulating electrical activity in an eye is provided. Provided is a technique for implanting small, nanometer-sized photoactive devices into an eye to improve electrical activity within an eye or mitigate degradation of electrical response in damaged eyes.
1. A method for increasing electrical activity within an eye, the method comprising:
implanting within the eye a biocompatible solution of a plurality of quantum dots, at least one of the plurality of quantum dots further comprising a bio-targeted encapsulation consisting of biotin,
wherein the bio-targeted encapsulation adheres directly to a targeted retinal cell and maintains the at least one of the plurality of quantum dots in close interaction with the targeted retinal cell for an extended period of time,
wherein, when light enters the eye, the at least one of the plurality of quantum dots fluoresces, thereby increasing electrical activity in a damaged retina comprising the targeted retinal cell, and
wherein the increase improves both the function and anatomy of the damaged retina.
2. The method of claim 1 , wherein the step of implanting includes implanting the plurality of quantum dots within a vitreous portion of the eye.
3. The method of claim 1 , wherein the step of implanting includes implanting the plurality of quantum dots within a sub-retinal portion of the eye.
4. The method of claim 1 , wherein the targeted retinal cell is a photoreceptor cell.
5. The method of claim 1 , wherein the targeted retinal cell is a sub-retinal cell.
6. The method of claim 1 , wherein the at least one of the plurality of quantum dots comprises a core formed of CdSe and a shell formed of ZnS.
7. The method of claim 1 , wherein the plurality of quantum dots fluoresces a plurality of colors.
8. The method of claim 1 , wherein the plurality of quantum dots emits a variety of electrical potentials in response to light of multiple wavelengths.
9. A photoactive device for stimulating electrical activity within an eye with retinal damage comprising:
a biocompatible solution of a plurality of quantum dots, at least one of the plurality of quantum dots further comprising a bio-targeted encapsulation consisting of biotin,
wherein the bio-targeted encapsulation is configured to adhere directly to a targeted retinal cell and maintain the at least one of the plurality of quantum dots in close interaction with the targeted retinal cell for an extended period of time,
wherein after the biocompatible solution is implanted within the eye and light enters the eye, the at least one of the plurality of quantum dots fluoresces, thereby increasing electrical activity in a damaged retina comprising the targeted retinal cell, and
wherein the increase improves both the function and anatomy of the damaged retina.
10. The photoactive device of claim 9 , wherein the targeted retinal cell is a sub-retinal cell.
11. The photoactive device of claim 9 , wherein the at least one of the plurality of quantum dots comprises a core formed of CdSe and a shell formed of ZnS.
12. The photoactive device of claim 9 , wherein the plurality of quantum dots fluoresces a plurality of colors.
13. The photoactive device of claim 9 , wherein the plurality of quantum dots emits a variety of electrical potentials in response to light of multiple wavelengths.